Composto, composição farmacêutica, e, formulação farmacêutica para administração tópica

Composto, composição farmacêutica, e, formulação farmacêutica para administração tópica

composto, composição farmacêutica, e, formulação farmacêutica para administração tópica. a presente invenção refere-se ao tratamento do lúpus eritematoso cutâneo. o problema a ser resolvido pela invenção é fornecer um novo uso farmacêutico de 3-[(3s,4r)-3-metil-6-(7h-pirrolo[2,3-d]pirimidina-4-il)-1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: NIELSEN JACOB, PIA KLIE REFER, SANDER CAMILLA, MORTENSEN HELENE, GITTE POMMERGAARD PEDERSEN
Format: Patent
Sprache:por
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator NIELSEN JACOB
PIA KLIE REFER
SANDER CAMILLA
MORTENSEN HELENE
GITTE POMMERGAARD PEDERSEN
description composto, composição farmacêutica, e, formulação farmacêutica para administração tópica. a presente invenção refere-se ao tratamento do lúpus eritematoso cutâneo. o problema a ser resolvido pela invenção é fornecer um novo uso farmacêutico de 3-[(3s,4r)-3-metil-6-(7h-pirrolo[2,3-d]pirimidina-4-il)-1,6-diazaspiro[3,4]octan-1-il]-3-oxopropanonitrila. agente terapêutico ou preventivo para lúpus eritematoso cutâneo, contendo 3-[(3s,4r)-3-metil-6-(7h-pirrolo[2,3-d]pirimidina-4-il)-1,6-diazaspiro[3.4]octan-1-il]-3-oxopropanonitrila como um ingrediente ativo e uma formulação farmacêutica do mesmo. The present invention relates to the treatment of cutaneous lupus erythematosus. The problem to be solved by the invention is to provide a new pharmaceutical use of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile, a therapeutic or preventive agent cutaneous lupus erythematosus, containing 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile as an active ingredient, and a pharmaceutical formulation thereof.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_BR112021022031A2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>BR112021022031A2</sourcerecordid><originalsourceid>FETCH-epo_espacenet_BR112021022031A23</originalsourceid><addsrcrecordid>eNrjZEhwzs8tyC8uyddRSAazMg8vP7w4XyEtsSg3MfnwqtKSzOREHYVUHYW0_KLc0pxELNIKBYlFiQqJKbmZeZnFJUVQJSWHNxcAJXkYWNMSc4pTeaE0N4Oqm2uIs4duakF-fGpxQWJyal5qSbxTkKGhkYGRoYGRkYGxoaORMbHqAOiMRNI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Composto, composição farmacêutica, e, formulação farmacêutica para administração tópica</title><source>esp@cenet</source><creator>NIELSEN JACOB ; PIA KLIE REFER ; SANDER CAMILLA ; MORTENSEN HELENE ; GITTE POMMERGAARD PEDERSEN</creator><creatorcontrib>NIELSEN JACOB ; PIA KLIE REFER ; SANDER CAMILLA ; MORTENSEN HELENE ; GITTE POMMERGAARD PEDERSEN</creatorcontrib><description>composto, composição farmacêutica, e, formulação farmacêutica para administração tópica. a presente invenção refere-se ao tratamento do lúpus eritematoso cutâneo. o problema a ser resolvido pela invenção é fornecer um novo uso farmacêutico de 3-[(3s,4r)-3-metil-6-(7h-pirrolo[2,3-d]pirimidina-4-il)-1,6-diazaspiro[3,4]octan-1-il]-3-oxopropanonitrila. agente terapêutico ou preventivo para lúpus eritematoso cutâneo, contendo 3-[(3s,4r)-3-metil-6-(7h-pirrolo[2,3-d]pirimidina-4-il)-1,6-diazaspiro[3.4]octan-1-il]-3-oxopropanonitrila como um ingrediente ativo e uma formulação farmacêutica do mesmo. The present invention relates to the treatment of cutaneous lupus erythematosus. The problem to be solved by the invention is to provide a new pharmaceutical use of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile, a therapeutic or preventive agent cutaneous lupus erythematosus, containing 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile as an active ingredient, and a pharmaceutical formulation thereof.</description><language>por</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2021</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211228&amp;DB=EPODOC&amp;CC=BR&amp;NR=112021022031A2$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20211228&amp;DB=EPODOC&amp;CC=BR&amp;NR=112021022031A2$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>NIELSEN JACOB</creatorcontrib><creatorcontrib>PIA KLIE REFER</creatorcontrib><creatorcontrib>SANDER CAMILLA</creatorcontrib><creatorcontrib>MORTENSEN HELENE</creatorcontrib><creatorcontrib>GITTE POMMERGAARD PEDERSEN</creatorcontrib><title>Composto, composição farmacêutica, e, formulação farmacêutica para administração tópica</title><description>composto, composição farmacêutica, e, formulação farmacêutica para administração tópica. a presente invenção refere-se ao tratamento do lúpus eritematoso cutâneo. o problema a ser resolvido pela invenção é fornecer um novo uso farmacêutico de 3-[(3s,4r)-3-metil-6-(7h-pirrolo[2,3-d]pirimidina-4-il)-1,6-diazaspiro[3,4]octan-1-il]-3-oxopropanonitrila. agente terapêutico ou preventivo para lúpus eritematoso cutâneo, contendo 3-[(3s,4r)-3-metil-6-(7h-pirrolo[2,3-d]pirimidina-4-il)-1,6-diazaspiro[3.4]octan-1-il]-3-oxopropanonitrila como um ingrediente ativo e uma formulação farmacêutica do mesmo. The present invention relates to the treatment of cutaneous lupus erythematosus. The problem to be solved by the invention is to provide a new pharmaceutical use of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile, a therapeutic or preventive agent cutaneous lupus erythematosus, containing 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile as an active ingredient, and a pharmaceutical formulation thereof.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2021</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZEhwzs8tyC8uyddRSAazMg8vP7w4XyEtsSg3MfnwqtKSzOREHYVUHYW0_KLc0pxELNIKBYlFiQqJKbmZeZnFJUVQJSWHNxcAJXkYWNMSc4pTeaE0N4Oqm2uIs4duakF-fGpxQWJyal5qSbxTkKGhkYGRoYGRkYGxoaORMbHqAOiMRNI</recordid><startdate>20211228</startdate><enddate>20211228</enddate><creator>NIELSEN JACOB</creator><creator>PIA KLIE REFER</creator><creator>SANDER CAMILLA</creator><creator>MORTENSEN HELENE</creator><creator>GITTE POMMERGAARD PEDERSEN</creator><scope>EVB</scope></search><sort><creationdate>20211228</creationdate><title>Composto, composição farmacêutica, e, formulação farmacêutica para administração tópica</title><author>NIELSEN JACOB ; PIA KLIE REFER ; SANDER CAMILLA ; MORTENSEN HELENE ; GITTE POMMERGAARD PEDERSEN</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_BR112021022031A23</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>por</language><creationdate>2021</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>NIELSEN JACOB</creatorcontrib><creatorcontrib>PIA KLIE REFER</creatorcontrib><creatorcontrib>SANDER CAMILLA</creatorcontrib><creatorcontrib>MORTENSEN HELENE</creatorcontrib><creatorcontrib>GITTE POMMERGAARD PEDERSEN</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>NIELSEN JACOB</au><au>PIA KLIE REFER</au><au>SANDER CAMILLA</au><au>MORTENSEN HELENE</au><au>GITTE POMMERGAARD PEDERSEN</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Composto, composição farmacêutica, e, formulação farmacêutica para administração tópica</title><date>2021-12-28</date><risdate>2021</risdate><abstract>composto, composição farmacêutica, e, formulação farmacêutica para administração tópica. a presente invenção refere-se ao tratamento do lúpus eritematoso cutâneo. o problema a ser resolvido pela invenção é fornecer um novo uso farmacêutico de 3-[(3s,4r)-3-metil-6-(7h-pirrolo[2,3-d]pirimidina-4-il)-1,6-diazaspiro[3,4]octan-1-il]-3-oxopropanonitrila. agente terapêutico ou preventivo para lúpus eritematoso cutâneo, contendo 3-[(3s,4r)-3-metil-6-(7h-pirrolo[2,3-d]pirimidina-4-il)-1,6-diazaspiro[3.4]octan-1-il]-3-oxopropanonitrila como um ingrediente ativo e uma formulação farmacêutica do mesmo. The present invention relates to the treatment of cutaneous lupus erythematosus. The problem to be solved by the invention is to provide a new pharmaceutical use of 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile, a therapeutic or preventive agent cutaneous lupus erythematosus, containing 3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile as an active ingredient, and a pharmaceutical formulation thereof.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language por
recordid cdi_epo_espacenet_BR112021022031A2
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Composto, composição farmacêutica, e, formulação farmacêutica para administração tópica
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T20%3A38%3A50IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=NIELSEN%20JACOB&rft.date=2021-12-28&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EBR112021022031A2%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true